Tysabri (natalizumab)

pCPA File Number: 20792

Negotiation Status:

Concluded with an LOI

Indication(s):

Relapsing-Remitting Multiple Sclerosis

Sponsor/Manufacturer:

Biogen Canada Inc.

CADTH Project Number:

S0133

pCPA Engagement Letter Issued:

2013-12-01

Negotiation Process Concluded:

2013-05-09